> Statins in trials show benefits for secondary events, but for primary protection statins don't actually work that well. This just simply isn't true and we ha

> Statins in trials show benefits for secondary events, but for primary protection statins don't actually work that well. This just simply isn't true and we have massive quantities of data pointing towards protection against major vascular events - even in people that we previously would have considered as having "normal" cholesterol. The NLA and AHA has been revising their guidelines to start getting people on statins sooner and to get levels lower for a reason - it works. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(12)60367-5/fulltext https://www.thelancet.com/journals/lancet/article/PIIS0140-6...